Twin Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Sell
735
-1,422
-66% -$467K 0.03% 271
2025
Q4
$756K Sell
2,157
-59
-3% -$19.9K 0.09% 193
2025
Q3
$716K Buy
2,216
+738
+50% +$230K 0.09% 197
2025
Q2
$575K Sell
1,478
-14
-0.9% -$5.63K 0.06% 220
2025
Q1
$649K Sell
1,492
-43
-3% -$17.3K 0.08% 211
2024
Q4
$566K Sell
1,535
-17
-1% -$7.11K 0.06% 236
2024
Q3
$807K Sell
1,552
-34
-2% -$18.2K 0.09% 192
2024
Q2
$859K Sell
1,586
-37
-2% -$19.6K 0.1% 187
2024
Q1
$842K Sell
1,623
-21
-1% -$10.4K 0.1% 192
2023
Q4
$775K Sell
1,644
-61
-4% -$28.2K 0.1% 193
2023
Q3
$742K Sell
1,705
-176
-9% -$79.8K 0.11% 188
2023
Q2
$836K Sell
1,881
-54
-3% -$24.9K 0.11% 188
2023
Q1
$890K Sell
1,935
-110
-5% -$52.3K 0.12% 184
2022
Q4
$1.05M Sell
2,045
-9
-0.4% -$4.57K 0.14% 172
2022
Q3
$933K Sell
2,054
-23
-1% -$11K 0.13% 186
2022
Q2
$1M Sell
2,077
-15
-0.7% -$7.42K 0.13% 182
2022
Q1
$1.03M Hold
2,092
0.11% 197
2021
Q4
$970K Sell
2,092
-130
-6% -$54.7K 0.1% 198
2021
Q3
$828K Buy
2,222
+15
+0.7% +$5.7K 0.08% 220
2021
Q2
$843K Sell
2,207
-10
-0.5% -$3.82K 0.08% 227
2021
Q1
$796K Sell
2,217
-260
-10% -$83.6K 0.08% 227
2020
Q4
$795K Sell
2,477
-15,096
-86% -$4.63M 0.07% 228
2020
Q3
$4.72M Sell
17,573
-201
-1% -$54.1K 0.43% 67
2020
Q2
$4.67M Sell
17,774
-1,332
-7% -$355K 0.45% 62
2020
Q1
$4.34M Sell
19,106
-160
-0.8% -$43.6K 0.47% 59
2019
Q4
$5.82M Sell
19,266
-16,713
-46% -$4.6M 0.49% 55
2019
Q3
$8.64M Sell
35,979
-2,481
-6% -$680K 0.63% 41
2019
Q2
$10.9M Sell
38,460
-15,200
-28% -$4.15M 0.76% 34
2019
Q1
$15.4M Buy
53,660
+170
+0.3% +$49.2K 0.76% 31
2018
Q4
$14M Sell
53,490
-10,440
-16% -$2.87M 0.79% 32
2018
Q3
$17.5M Buy
63,930
+2,750
+4% +$714K 0.8% 30
2018
Q2
$14.6M Sell
61,180
-4,262
-7% -$987K 0.73% 34
2018
Q1
$14.4M Buy
65,442
+202
+0.3% +$47.5K 0.74% 31
2017
Q4
$14.7M Buy
65,240
+1,180
+2% +$251K 0.72% 36
2017
Q3
$12.2M Buy
64,060
+6,990
+12% +$1.33M 0.64% 40
2017
Q2
$10.7M Buy
57,070
+3,380
+6% +$607K 0.63% 41
2017
Q1
$8.88M Sell
53,690
-630
-1% -$100K 0.55% 49
2016
Q4
$7.81M Sell
54,320
-840
-2% -$112K 0.5% 56
2016
Q3
$6.91M Buy
55,160
+8,590
+18% +$1.11M 0.46% 60
2016
Q2
$6.12M Sell
46,570
-5,000
-10% -$684K 0.46% 60
2016
Q1
$7.17M Buy
51,570
+1,420
+3% +$190K 0.56% 48
2015
Q4
$6.99M Buy
50,150
+7,240
+17% +$997K 0.57% 50
2015
Q3
$6.01M Sell
42,910
-8,270
-16% -$1.24M 0.57% 48
2015
Q2
$8.4M Sell
51,180
-3,980
-7% -$636K 0.75% 36
2015
Q1
$8.52M Buy
55,160
+7,300
+15% +$1.04M 0.75% 31
2014
Q4
$6.01M Buy
47,860
+3,990
+9% +$493K 0.57% 46
2014
Q3
$5.25M Sell
43,870
-670
-2% -$76.8K 0.53% 49
2014
Q2
$4.79M Sell
44,540
-2,030
-4% -$209K 0.48% 50
2014
Q1
$4.64M Sell
46,570
-970
-2% -$87.7K 0.49% 52
2013
Q4
$4.39M Buy
47,540
+6,576
+16% +$584K 0.47% 51
2013
Q3
$3.42M Sell
40,964
-1,150
-3% -$98.6K 0.37% 76
2013
Q2
$3.45M Buy
+42,114
New +$3.15M 0.37% 69

Other funds holding ELV

Twin Capital Management's ELV Position: Q1 2026 in Review

Twin Capital Management reduced its Elevance Health (ELV) stake by 66% in Q1 2026, selling an estimated $467K and leaving 735 shares worth $215K. The position accounts for 0.03% of the portfolio, ranked #271.

Twin Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.5M in Q3 2018. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Twin Capital Management held 735 shares of Elevance Health worth $215K as of Q1 2026.
  • Twin Capital Management sold 1,422 Elevance Health shares in Q1 2026, an estimated $467K.
  • Elevance Health made up 0.03% of Twin Capital Management's portfolio in Q1 2026, its #271 holding.
  • Twin Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Twin Capital Management's Elevance Health position peaked at $17.5M in Q3 2018.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.